Stay updated on Pembrolizumab Combo in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page
- CheckyesterdayChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a minor update to the page's revision metadata. The change does not modify visible content or functionality.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA Publications section was added to the study record, listing a Nat Commun article about the related pembrolizumab/DPX-Survivac/cyclophosphamide trial and noting that publications are automatically filled from PubMed (Revision: v3.5.4).SummaryDifference0.3%

- Check30 days agoChange DetectedThere are no textual changes listed for this page in the provided data.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page footer was updated from “Revision: v3.5.0” to “Revision: v3.5.3,” reflecting a new ClinicalTrials.gov site/record display revision without changing the study details.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision: v3.5.0 is now displayed, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check95 days agoChange DetectedAdded revision note for v3.4.3 and removed the previous v3.4.2 revision.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page.